The ADVANCE trial: Phase 3, randomized comparison of TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV for first-line treatment of HIV-1 infectionW. F. Venter,M. Moorhouse,S. Sokhela, L. Fairlee, N. Mashabane, M. Masenya,A. Qavi,P. Clayden,E. J. Abrams,B. Simmons,A. HillJOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2019）引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
